Home Cart Sign in  
Chemical Structure| 1467093-03-3 Chemical Structure| 1467093-03-3

Structure of Adavivint
CAS No.: 1467093-03-3

Chemical Structure| 1467093-03-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Adavivint is a potent and selective inhibitor of canonical Wnt signaling, with an EC50 of 19.5 nM via a high-throughput TCF/LEF-reporter assay in SW480 colon cancer cells.

Synonyms: SM04690; Lorecivivint

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Adavivint

CAS No. :1467093-03-3
Formula : C29H24FN7O
M.W : 505.55
SMILES Code : CC(C)CC(NC1=CC(C2=CC3=C(NN=C3C(N4)=NC5=C4C=NC=C5C6=CC=CC(F)=C6)C=C2)=CN=C1)=O
Synonyms :
SM04690; Lorecivivint
MDL No. :MFCD30489411
InChI Key :AQDWDWAYVBQMAM-UHFFFAOYSA-N
Pubchem ID :135565709

Safety of Adavivint

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CRC organoids 1 μM 96 hours Evaluate the anti-tumor activity and low toxicity of Adavivint in CRC organoids PMC11744699
SW620 cells 1 µM 72 hours To investigate the activation of PEPT1 transcription by DAC, results showed DAC activated PEPT1 transcription in a dose-dependent manner. PMC10049556
SW480 cells 1 µM 72 hours To investigate the activation of PEPT1 transcription by DAC, results showed DAC activated PEPT1 transcription in a dose-dependent manner. PMC10049556
RKO cells 1 µM 72 hours To test the effect of SQLE knockdown on 5-FU sensitivity, results showed that SQLE knockdown increased the sensitivity of tumor cells to 5-FU treatment. PMC10049556

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice PDOX model Intraperitoneal injection 5 and 50 mg/kg Once daily for one week Evaluate the inhibitory effect of Adavivint on CRC growth in vivo PMC11744699

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03706521 Knee Osteoarthritis PHASE2 TERMINATED 2020-12-21 Research Site, San Francisco, ... More >>California, 94158, United States Less <<
NCT04931667 Osteoarthritis of the Knee PHASE3 TERMINATED 2021-12-13 Research Site, Tucson, Arizona... More >>, 85712, United States|Research Site, Winter Park, Florida, 32789, United States|Research Site, Oak Brook, Illinois, 60523, United States|Research Site, Dallas, Texas, 75231, United States Less <<
NCT03246399 Degenerative Disc Disease PHASE1 TERMINATED 2018-12-04 Research Site, San Diego, Cali... More >>fornia, 92103, United States|Research Site, Charleston, South Carolina, 29406, United States|Research Site, Tyler, Texas, 75701, United States|Research Site, Richmond, Virginia, 23235, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.98mL

0.40mL

0.20mL

9.89mL

1.98mL

0.99mL

19.78mL

3.96mL

1.98mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories